Palatin Technologies (PTN) Accounts Payables (2011 - 2026)
Palatin Technologies' (PTN) quarterly Accounts Payables came in at $1.7 million in Q1 2026, down 78.21% on a YoY basis from $7.8 million in Q1 2025, and down 68.95% quarter-over-quarter from $5.5 million in Q4 2025.
Analysis
Palatin Technologies (PTN) Accounts Payables (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Accounts Payables for 15 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 78.21% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 78.21% YoY), and the FY2025 full-year result was $7.0 million, up 70.62% from the prior year.
- Accounts Payables fell to $1.7 million in Q1 2026 per PTN's latest filing, from $5.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $7.8 million in Q1 2025 and bottomed at $820304.0 in Q4 2022.
- Historically, Accounts Payables has averaged $4.0 million across 5 years, with a median of $3.8 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Accounts Payables jumped 412.11% in 2022, then slumped 78.21% in 2026.
- Over 5 years, Accounts Payables stood at $820304.0 in 2022, then jumped by 94.25% to $1.6 million in 2023, then jumped by 321.61% to $6.7 million in 2024, then fell by 18.83% to $5.5 million in 2025, then slumped by 68.95% to $1.7 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.7 million, $5.5 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | 1.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 5.45 Mn |
| Sep 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 6.72 Mn |
| Sep 30, 2024 | 3.95 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 2.79 Mn |
| Dec 31, 2022 | 820,304.00 |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 2.40 Mn |
| Dec 31, 2021 | 160,180.00 |
| Sep 30, 2021 | 762,817.00 |
| Jun 30, 2021 | 640,650.00 |